Your browser doesn't support javascript.
loading
Cardiovascular human organ-on-a-chip platform for disease modeling, drug development, and personalized therapy.
Khanna, Astha; Oropeza, Beu P; Huang, Ngan F.
Affiliation
  • Khanna A; Graver Technologies, Newark, New Jersey, USA.
  • Oropeza BP; Department of Cardiothoracic Surgery, Stanford University, Stanford, California, USA.
  • Huang NF; Stanford Cardiovascular Institute, Stanford University, Stanford, California, USA.
J Biomed Mater Res A ; 112(4): 512-523, 2024 04.
Article in En | MEDLINE | ID: mdl-37668192
Cardiovascular organ-on-a-chip (OoC) devices are composed of engineered or native functional tissues that are cultured under controlled microenvironments inside microchips. These systems employ microfabrication and tissue engineering techniques to recapitulate human physiology. This review focuses on human OoC systems to model cardiovascular diseases, to perform drug screening, and to advance personalized medicine. We also address the challenges in the generation of organ chips that can revolutionize the large-scale application of these systems for drug development and personalized therapy.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lab-On-A-Chip Devices / Microphysiological Systems Limits: Humans Language: En Journal: J Biomed Mater Res A Journal subject: ENGENHARIA BIOMEDICA Year: 2024 Document type: Article Affiliation country: United States Country of publication: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Lab-On-A-Chip Devices / Microphysiological Systems Limits: Humans Language: En Journal: J Biomed Mater Res A Journal subject: ENGENHARIA BIOMEDICA Year: 2024 Document type: Article Affiliation country: United States Country of publication: United States